| (+)-pilocarpine | increases expression | ISO | RGD:620800 | 6480464 | Pilocarpine results in increased expression of BNIP3 mRNA | CTD | PMID:17971868 |
| (S)-nicotine | multiple interactions | EXP | | 6480464 | [Nicotine co-treated with 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine] results in increased expression of BNIP3 mRNA; more ... | CTD | PMID:20230807 |
| 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine | increases expression | EXP | | 6480464 | 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in increased expression of BNIP3 mRNA | CTD | PMID:20230807 |
| 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine | multiple interactions | EXP | | 6480464 | [Caffeine co-treated with 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine] results in increased expression of BNIP3 mRNA; more ... | CTD | PMID:20230807 |
| 17alpha-ethynylestradiol | affects expression | EXP | | 6480464 | Ethinyl Estradiol affects the expression of BNIP3 mRNA | CTD | PMID:17555576 |
| 17alpha-ethynylestradiol | decreases expression | EXP | | 6480464 | Ethinyl Estradiol results in decreased expression of BNIP3 mRNA | CTD | PMID:17942748 |
| 17alpha-ethynylestradiol | multiple interactions | EXP | | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in decreased expression of BNIP3 mRNA | CTD | PMID:17942748 |
| 1H-pyrazole | decreases expression | EXP | | 6480464 | pyrazole results in decreased expression of BNIP3 mRNA | CTD | PMID:17945193 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | EXP | | 6480464 | [decitabine co-treated with Tetrachlorodibenzodioxin] results in decreased expression of BNIP3 mRNA | CTD | PMID:15251184 |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of BNIP3 mRNA | CTD | PMID:15251184 PMID:15667827 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of BNIP3 mRNA | CTD | PMID:21041162 |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of BNIP3 mRNA | CTD | PMID:15667827 PMID:15251184 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | EXP | | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in decreased expression of BNIP3 mRNA | CTD | PMID:17942748 |
| 2-methoxyethanol | increases expression | ISO | RGD:620800 | 6480464 | methyl cellosolve results in increased expression of BNIP3 mRNA | CTD | PMID:21061450 |
| 3,3',4,4'-tetrachlorobiphenyl | multiple interactions | EXP | | 6480464 | 3,4,3',4'-tetrachlorobiphenyl inhibits the reaction [Dietary Fats results in increased expression of BNIP3 mRNA] | CTD | PMID:19467301 |
| 4-hydroxynon-2-enal | decreases expression | ISO | RGD:1350913 | 6480464 | 4-hydroxy-2-nonenal results in decreased expression of BNIP3 mRNA | CTD | PMID:12419474 |
| 5-aza-2'-deoxycytidine | multiple interactions | EXP | | 6480464 | [decitabine co-treated with Tetrachlorodibenzodioxin] results in decreased expression of BNIP3 mRNA | CTD | PMID:15251184 |
| 5-aza-2'-deoxycytidine | decreases methylation | ISO | RGD:1350913 | 6480464 | decitabine results in decreased methylation of BNIP3 promoter | CTD | PMID:17195906 PMID:15942716 |
| 5-aza-2'-deoxycytidine | multiple interactions | ISO | RGD:1350913 | 6480464 | [decitabine results in decreased methylation of BNIP3 promoter] which results in increased expression of BNIP3 mRNA | CTD | PMID:17195906 PMID:17195906 |
| 5-aza-2'-deoxycytidine | increases expression | ISO | RGD:1350913 | 6480464 | decitabine results in increased expression of BNIP3 mRNA | CTD | PMID:15942716 PMID:16367923 |
| 5-aza-2'-deoxycytidine | increases expression | ISO | RGD:1350913 | 6480464 | decitabine results in increased expression of BNIP3 protein | CTD | PMID:19732952 |
| 5-aza-2'-deoxycytidine | decreases expression | EXP | | 6480464 | decitabine results in decreased expression of BNIP3 mRNA | CTD | PMID:15251184 |
| 5-aza-2'-deoxycytidine | multiple interactions | ISO | RGD:1350913 | 6480464 | [decitabine results in decreased methylation of BNIP3 promoter] which results in increased expression of BNIP3 mRNA | CTD | PMID:17195906 |
| 5-aza-2'-deoxycytidine | decreases methylation | ISO | RGD:1350913 | 6480464 | decitabine results in decreased methylation of BNIP3 promoter | CTD | PMID:15942716 PMID:17195906 |
| 5-aza-2'-deoxycytidine | increases expression | ISO | RGD:1350913 | 6480464 | decitabine results in increased expression of BNIP3 mRNA | CTD | PMID:16367923 PMID:15942716 |
| 5-fluorouracil | multiple interactions | ISO | RGD:1350913 | 6480464 | TP53 protein affects the reaction [Fluorouracil results in decreased expression of BNIP3 mRNA] | CTD | PMID:15016801 |
| 5-fluorouracil | affects response to substance | ISO | RGD:1350913 | 6480464 | BNIP3 affects the susceptibility to Fluorouracil | CTD | PMID:15067352 |
| 6-propyl-2-thiouracil | affects expression | ISO | RGD:620800 | 6480464 | Propylthiouracil affects the expression of BNIP3 mRNA | CTD | PMID:19483382 |
| actinomycin D | multiple interactions | EXP | | 6480464 | [Dactinomycin co-treated with TNF protein] results in increased expression of BNIP3 mRNA | CTD | PMID:11592958 |
| actinomycin D | multiple interactions | EXP | | 6480464 | Dactinomycin inhibits the reaction [manganese chloride results in increased expression of BNIP3 protein] | CTD | PMID:19442826 |
| all-trans-retinoic acid | multiple interactions | EXP | | 6480464 | SOX11 protein promotes the reaction [Tretinoin results in increased expression of BNIP3 mRNA] | CTD | PMID:17055661 |
| amiodarone | affects expression | ISO | RGD:620800 | 6480464 | Amiodarone affects the expression of BNIP3 mRNA | CTD | PMID:19483382 |
| ammonium chloride | affects expression | ISO | RGD:620800 | 6480464 | Ammonium Chloride affects the expression of BNIP3 mRNA | CTD | PMID:16483693 |
| antimycin A | increases expression | EXP | | 6480464 | Antimycin A results in increased expression of BNIP3 mRNA | CTD | PMID:19304788 |
| benzbromarone | affects expression | ISO | RGD:620800 | 6480464 | Benzbromarone affects the expression of BNIP3 mRNA | CTD | PMID:19483382 |
| benzene | multiple interactions | ISO | RGD:620800 | 6480464 | [Benzene co-treated with methylmercury II co-treated with Trichloroethylene] results in increased expression of BNIP3 mRNA | CTD | PMID:17905399 |
| benzo[a]pyrene | increases expression | EXP | | 6480464 | Benzo(a)pyrene results in increased expression of BNIP3 mRNA | CTD | PMID:21569818 |
| bezafibrate | increases expression | EXP | | 6480464 | Bezafibrate results in increased expression of BNIP3 mRNA | CTD | PMID:17118139 |
| bicalutamide | increases expression | ISO | RGD:1350913 | 6480464 | bicalutamide results in increased expression of BNIP3 mRNA | CTD | PMID:15790403 |
| cadmium dichloride | increases expression | ISO | RGD:1350913 | 6480464 | Cadmium Chloride results in increased expression of BNIP3 mRNA | CTD | PMID:12760830 |
| caffeine | multiple interactions | EXP | | 6480464 | [Caffeine co-treated with 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine] results in increased expression of BNIP3 mRNA; more ... | CTD | PMID:20230807 |
| capsaicin | decreases expression | ISO | RGD:1350913 | 6480464 | Capsaicin results in decreased expression of BNIP3 mRNA | CTD | PMID:19502594 |
| ciguatoxin CTX1B | affects expression | EXP | | 6480464 | Ciguatoxins affects the expression of BNIP3 mRNA | CTD | PMID:18353800 |
| cisplatin | increases expression | EXP | | 6480464 | Cisplatin results in increased expression of BNIP3 mRNA | CTD | PMID:21074548 |
| cisplatin | increases expression | ISO | RGD:620800 | 6480464 | Cisplatin results in increased expression of BNIP3 mRNA | CTD | PMID:21575413 |
| cisplatin | increases phosphorylation | EXP | | 6480464 | Cisplatin results in increased phosphorylation of BNIP3 protein | CTD | PMID:22006019 |
| clofibrate | affects expression | ISO | RGD:620800 | 6480464 | Clofibrate affects the expression of BNIP3 mRNA | CTD | PMID:19483382 |
| cobalt atom | multiple interactions | ISO | RGD:1350913 | 6480464 | [tungsten carbide binds to Cobalt] which results in increased expression of BNIP3 mRNA | CTD | PMID:20105288 |
| cobalt atom | multiple interactions | ISO | RGD:1350913 | 6480464 | [tungsten carbide co-treated with Cobalt] results in increased expression of BNIP3 mRNA | CTD | PMID:18078969 |
| cobalt dichloride | increases expression | ISO | RGD:1350913 | 6480464 | cobaltous chloride results in increased expression of BNIP3 mRNA | CTD | PMID:20105288 |
| cobalt dichloride | increases expression | ISO | RGD:1350913 | 6480464 | cobaltous chloride results in increased expression of BNIP3 mRNA | CTD | PMID:19320972 more ... |
| cobalt dichloride | increases expression | ISO | RGD:1350913 | 6480464 | cobaltous chloride results in increased expression of BNIP3 mRNA | CTD | PMID:19320972 more ... |
| cobalt dichloride | multiple interactions | ISO | RGD:1350913 | 6480464 | peoniflorin inhibits the reaction [cobaltous chloride results in increased expression of BNIP3 mRNA] | CTD | PMID:22269387 |
| cobalt dichloride | increases expression | ISO | RGD:1350913 | 6480464 | cobaltous chloride results in increased expression of BNIP3 mRNA | CTD | PMID:20105288 more ... |
| cobalt dichloride | increases expression | EXP | | 6480464 | cobaltous chloride results in increased expression of BNIP3 mRNA | CTD | PMID:15375294 PMID:17169330 |
| cobalt dichloride | increases expression | EXP | | 6480464 | cobaltous chloride results in increased expression of BNIP3 mRNA | CTD | PMID:17169330 PMID:15375294 |
| cobalt dichloride | increases expression | EXP | | 6480464 | cobaltous chloride results in increased expression of BNIP3 protein | CTD | PMID:15375294 |
| cocaine | affects expression | EXP | | 6480464 | Cocaine affects the expression of BNIP3 mRNA | CTD | PMID:15681117 |
| copper atom | multiple interactions | EXP | | 6480464 | [ATP7A gene mutant form results in increased abundance of Copper] which results in decreased expression of BNIP3 mRNA | CTD | PMID:15467011 |
| copper(0) | multiple interactions | EXP | | 6480464 | [ATP7A gene mutant form results in increased abundance of Copper] which results in decreased expression of BNIP3 mRNA | CTD | PMID:15467011 |
| copper(2+) sulfate | decreases expression | ISO | RGD:1350913 | 6480464 | Copper Sulfate results in decreased expression of BNIP3 mRNA | CTD | PMID:19549813 |
| cycloheximide | multiple interactions | EXP | | 6480464 | Cycloheximide inhibits the reaction [manganese chloride results in increased expression of BNIP3 protein] | CTD | PMID:19442826 |
| cyclosporin A | decreases expression | ISO | RGD:1350913 | 6480464 | Cyclosporine results in decreased expression of BNIP3 mRNA | CTD | PMID:21632981 |
| deoxycholic acid | affects response to substance | ISO | RGD:1350913 | 6480464 | BNIP3 protein affects the susceptibility to Deoxycholic Acid | CTD | PMID:12507930 |
| dexamethasone | increases expression | EXP | | 6480464 | Dexamethasone results in increased expression of BNIP3 mRNA | CTD | PMID:21041162 |
| diarsenic trioxide | increases expression | ISO | RGD:1350913 | 6480464 | arsenic trioxide results in increased expression of BNIP3 mRNA | CTD | PMID:15592527 PMID:17530438 |
| diarsenic trioxide | increases expression | ISO | RGD:1350913 | 6480464 | arsenic trioxide results in increased expression of BNIP3 mRNA | CTD | PMID:17530438 PMID:15592527 |
| diarsenic trioxide | increases response to substance | ISO | RGD:1350913 | 6480464 | BNIP3 protein results in increased susceptibility to arsenic trioxide | CTD | PMID:15592527 |
| diarsenic trioxide | decreases expression | ISO | RGD:620800 | 6480464 | arsenic trioxide results in decreased expression of BNIP3 mRNA | CTD | PMID:19730151 |
| diarsenic trioxide | increases expression | ISO | RGD:1350913 | 6480464 | arsenic trioxide results in increased expression of BNIP3 protein | CTD | PMID:15592527 |
| diazoxide | increases expression | EXP | | 6480464 | Isoproterenol results in increased expression of BNIP3 mRNA | CTD | PMID:20003209 |
| dibutyl phthalate | decreases expression | EXP | | 6480464 | Dibutyl Phthalate results in decreased expression of BNIP3 mRNA | CTD | PMID:21266533 |
| diethylstilbestrol | increases expression | EXP | | 6480464 | Diethylstilbestrol results in increased expression of BNIP3 mRNA | CTD | PMID:21041162 |
| dioxygen | increases expression | ISO | RGD:1350913 | 6480464 | Oxygen deficiency results in increased expression of BNIP3 mRNA | CTD | PMID:17914565 |
| dioxygen | increases expression | EXP | | 6480464 | Oxygen deficiency results in increased expression of BNIP3 mRNA | CTD | PMID:20880076 |
| dioxygen | affects expression | EXP | | 6480464 | Oxygen deficiency affects the expression of BNIP3 mRNA | CTD | PMID:17193925 |
| dioxygen | increases expression | ISO | RGD:1350913 | 6480464 | Oxygen deficiency results in increased expression of BNIP3 mRNA | CTD | PMID:17914565 PMID:20042640 |
| dopamine | increases expression | ISO | RGD:1350913 | 6480464 | [Dopamine results in increased expression of HIF1A protein] which results in increased expression of BNIP3 mRNA; more ... | CTD | PMID:19410601 |
| doxorubicin | increases expression | EXP | | 6480464 | Doxorubicin results in increased expression of BNIP3 mRNA | CTD | PMID:19001878 |
| doxorubicin | decreases expression | ISO | RGD:1350913 | 6480464 | Doxorubicin results in decreased expression of BNIP3 mRNA | CTD | PMID:22908232 |
| doxorubicin | multiple interactions | EXP | | 6480464 | PARP1 protein promotes the reaction [Doxorubicin results in increased expression of BNIP3 mRNA] | CTD | PMID:19001878 |
| flurbiprofen | increases expression | EXP | | 6480464 | Flurbiprofen results in increased expression of BNIP3 mRNA | CTD | PMID:16949054 |
| folic acid | affects expression | ISO | RGD:1350913 | 6480464 | Folic Acid affects the expression of BNIP3 mRNA | CTD | PMID:17320366 |
| glutathione | multiple interactions | EXP | | 6480464 | Glutathione inhibits the reaction [manganese chloride results in increased expression of BNIP3 protein] | CTD | PMID:19442826 |
| hydrogen peroxide | affects expression | ISO | RGD:1350913 | 6480464 | Hydrogen Peroxide affects the expression of BNIP3 mRNA | CTD | PMID:20044591 |
| hydrogen peroxide | decreases expression | ISO | RGD:1350913 | 6480464 | Hydrogen Peroxide results in decreased expression of BNIP3 mRNA | CTD | PMID:12419474 |
| hydroquinone | decreases expression | ISO | RGD:1350913 | 6480464 | hydroquinone results in decreased expression of BNIP3 mRNA | CTD | PMID:15452088 |
| isoflurane | increases expression | ISO | RGD:620800 | 6480464 | Isoflurane results in increased expression of BNIP3 mRNA | CTD | PMID:16978161 |
| isoprenaline | increases expression | EXP | | 6480464 | Isoproterenol results in increased expression of BNIP3 mRNA | CTD | PMID:20003209 |
| ketamine | decreases expression | ISO | RGD:620800 | 6480464 | Ketamine results in decreased expression of BNIP3 mRNA | CTD | PMID:20080153 |
| L-ethionine | affects expression | ISO | RGD:620800 | 6480464 | Ethionine affects the expression of BNIP3 mRNA | CTD | PMID:19483382 |
| manganese atom | multiple interactions | EXP | | 6480464 | Antioxidants inhibits the reaction [Manganese results in increased expression of BNIP3 protein] | CTD | PMID:19442826 |
| manganese(0) | multiple interactions | EXP | | 6480464 | Antioxidants inhibits the reaction [Manganese results in increased expression of BNIP3 protein] | CTD | PMID:19442826 |
| manganese(II) chloride | multiple interactions | EXP | | 6480464 | Acetylcysteine inhibits the reaction [manganese chloride results in increased expression of BNIP3 protein]; more ... | CTD | PMID:19442826 |
| manganese(II) chloride | affects response to substance | EXP | | 6480464 | BNIP3 protein affects the susceptibility to manganese chloride | CTD | PMID:19442826 |
| methotrexate | affects expression | EXP | | 6480464 | Methotrexate affects the expression of BNIP3 mRNA | CTD | PMID:18502557 |
| methotrexate | affects response to substance | ISO | RGD:1350913 | 6480464 | BNIP3 protein affects the susceptibility to Methotrexate | CTD | PMID:16217747 |
| methylmercury(1+) | multiple interactions | ISO | RGD:620800 | 6480464 | [Benzene co-treated with methylmercury II co-treated with Trichloroethylene] results in increased expression of BNIP3 mRNA | CTD | PMID:17905399 |
| N-acetyl-L-cysteine | multiple interactions | EXP | | 6480464 | Acetylcysteine inhibits the reaction [manganese chloride results in increased expression of BNIP3 protein] | CTD | PMID:19442826 |
| N-methyl-4-phenylpyridinium | decreases expression | EXP | | 6480464 | 1-Methyl-4-phenylpyridinium results in decreased expression of BNIP3 mRNA; more ... | CTD | PMID:22776087 |
| N-methyl-4-phenylpyridinium | decreases expression | EXP | | 6480464 | 1-Methyl-4-phenylpyridinium results in decreased expression of BNIP3 mRNA | CTD | PMID:17475336 more ... |
| nickel dichloride | increases expression | EXP | | 6480464 | nickel chloride results in increased expression of BNIP3 mRNA | CTD | PMID:12839937 |
| nickel dichloride | increases expression | EXP | | 6480464 | nickel chloride results in increased expression of BNIP3 mRNA | CTD | PMID:12426141 more ... |
| nickel dichloride | increases expression | EXP | | 6480464 | nickel chloride results in increased expression of BNIP3 mRNA | CTD | PMID:12729255 more ... |
| nickel dichloride | multiple interactions | EXP | | 6480464 | HIF1A affects the reaction [nickel chloride results in increased expression of BNIP3 mRNA] | CTD | PMID:12729255 PMID:12426141 |
| nickel dichloride | increases expression | ISO | RGD:1350913 | 6480464 | nickel chloride results in increased expression of BNIP3 mRNA | CTD | PMID:17312168 |
| nickel dichloride | increases expression | EXP | | 6480464 | nickel chloride results in increased expression of BNIP3 mRNA | CTD | PMID:12839937 more ... |
| nickel dichloride | multiple interactions | EXP | | 6480464 | HIF1A affects the reaction [nickel chloride results in increased expression of BNIP3 mRNA] | CTD | PMID:12426141 PMID:12729255 |
| nickel dichloride | affects expression | ISO | RGD:620800 | 6480464 | nickel chloride affects the expression of BNIP3 mRNA | CTD | PMID:22110744 |
| nitric oxide | increases expression | ISO | RGD:620800 | 6480464 | Nitric Oxide results in increased expression of BNIP3 protein | CTD | PMID:16002567 |
| nitric oxide | decreases expression | EXP | | 6480464 | Nitric Oxide results in decreased expression of BNIP3 mRNA | CTD | PMID:11592958 |
| ochratoxin A | increases expression | ISO | RGD:620800 | 6480464 | ochratoxin A results in increased expression of BNIP3 mRNA | CTD | PMID:19562491 |
| omeprazole | affects expression | ISO | RGD:620800 | 6480464 | Omeprazole affects the expression of BNIP3 mRNA | CTD | PMID:19483382 |
| oxaliplatin | decreases expression | ISO | RGD:1350913 | 6480464 | oxaliplatin results in decreased expression of BNIP3 mRNA | CTD | PMID:17762391 |
| paracetamol | multiple interactions | ISO | RGD:1350913 | 6480464 | [Dietary Carbohydrates co-treated with Acetaminophen] results in decreased expression of BNIP3 mRNA | CTD | PMID:17093179 |
| paraquat | decreases expression | ISO | RGD:1350913 | 6480464 | Paraquat results in decreased expression of BNIP3 mRNA | CTD | PMID:18836921 |
| pentobarbital | increases expression | ISO | RGD:620800 | 6480464 | Pentobarbital results in increased expression of BNIP3 mRNA | CTD | PMID:16978161 |
| peroxynitrous acid | increases expression | ISO | RGD:1350913 | 6480464 | Peroxynitrous Acid results in increased expression of BNIP3 protein | CTD | PMID:16002567 |
| pirinixic acid | affects expression | ISO | RGD:620800 | 6480464 | pirinixic acid affects the expression of BNIP3 mRNA | CTD | PMID:19483382 |
| pirinixic acid | increases expression | EXP | | 6480464 | pirinixic acid results in increased expression of BNIP3 mRNA | CTD | PMID:17426115 PMID:17118139 |
| pirinixic acid | increases expression | EXP | | 6480464 | pirinixic acid results in increased expression of BNIP3 mRNA | CTD | PMID:17118139 PMID:17426115 |
| propiconazole | decreases expression | EXP | | 6480464 | propiconazole results in decreased expression of BNIP3 mRNA | CTD | PMID:21278054 |
| propofol | multiple interactions | EXP | | 6480464 | Propofol inhibits the reaction [Lipopolysaccharides results in increased expression of BNIP3 protein]; more ... | CTD | PMID:21307008 |
| quercetin | affects expression | ISO | RGD:620800 | 6480464 | Quercetin affects the expression of BNIP3 mRNA | CTD | PMID:18178720 |
| quercetin | decreases expression | ISO | RGD:1350913 | 6480464 | Quercetin results in decreased expression of BNIP3 mRNA | CTD | PMID:21632981 |
| quercetin | increases expression | ISO | RGD:1350913 | 6480464 | Quercetin results in increased expression of BNIP3 mRNA | CTD | PMID:19729006 |
| ranitidine | multiple interactions | ISO | RGD:620800 | 6480464 | [Lipopolysaccharides co-treated with Ranitidine] results in increased expression of BNIP3 mRNA | CTD | PMID:16401727 PMID:16415329 |
| ranitidine | multiple interactions | ISO | RGD:620800 | 6480464 | [Lipopolysaccharides co-treated with Ranitidine] results in increased expression of BNIP3 mRNA | CTD | PMID:16415329 PMID:16401727 |
| rotenone | increases expression | EXP | | 6480464 | Rotenone results in increased expression of BNIP3 mRNA | CTD | PMID:19304788 |
| S-nitrosoglutathione | decreases expression | EXP | | 6480464 | S-Nitrosoglutathione results in decreased expression of BNIP3 mRNA | CTD | PMID:11592958 |
| simvastatin | increases expression | ISO | RGD:1350913 | 6480464 | Simvastatin results in increased expression of BNIP3 mRNA | CTD | PMID:17428261 |
| sirolimus | multiple interactions | EXP | | 6480464 | Sirolimus inhibits the reaction [IL2 protein results in increased expression of BNIP3 mRNA] | CTD | PMID:11355896 |
| tamoxifen | affects expression | EXP | | 6480464 | Tamoxifen affects the expression of BNIP3 mRNA | CTD | PMID:17555576 |
| tert-butyl hydroperoxide | decreases expression | ISO | RGD:1350913 | 6480464 | tert-Butylhydroperoxide results in decreased expression of BNIP3 mRNA | CTD | PMID:12419474 |
| tert-butyl hydroperoxide | increases expression | EXP | | 6480464 | tert-Butylhydroperoxide results in increased expression of BNIP3 mRNA | CTD | PMID:15003993 |
| tetrachloromethane | decreases expression | EXP | | 6480464 | Carbon Tetrachloride results in decreased expression of BNIP3 mRNA | CTD | PMID:17084009 |
| tetrachloromethane | multiple interactions | EXP | | 6480464 | CYP2E1 gene mutant form inhibits the reaction [Carbon Tetrachloride results in decreased expression of BNIP3 mRNA] | CTD | PMID:17084009 |
| tetrachloromethane | increases expression | EXP | | 6480464 | Carbon Tetrachloride results in increased expression of BNIP3 mRNA | CTD | PMID:17484886 |
| tetrachloromethane | affects expression | ISO | RGD:620800 | 6480464 | Carbon Tetrachloride affects the expression of BNIP3 mRNA | CTD | PMID:15963342 |
| thioacetamide | affects expression | ISO | RGD:620800 | 6480464 | Thioacetamide affects the expression of BNIP3 mRNA | CTD | PMID:19483382 |
| trichloroethene | multiple interactions | EXP | | 6480464 | PPARA protein inhibits the reaction [Trichloroethylene results in increased expression of BNIP3 protein] | CTD | PMID:15363585 |
| trichloroethene | increases expression | EXP | | 6480464 | Trichloroethylene results in increased expression of BNIP3 mRNA | CTD | PMID:15363585 |
| trichloroethene | multiple interactions | ISO | RGD:620800 | 6480464 | [Benzene co-treated with methylmercury II co-treated with Trichloroethylene] results in increased expression of BNIP3 mRNA | CTD | PMID:17905399 |
| valproic acid | affects expression | EXP | | 6480464 | Valproic Acid affects the expression of BNIP3 mRNA | CTD | PMID:17963808 PMID:17292431 |
| valproic acid | affects expression | EXP | | 6480464 | Valproic Acid affects the expression of BNIP3 mRNA | CTD | PMID:17292431 PMID:17963808 |
| valproic acid | decreases expression | ISO | RGD:1350913 | 6480464 | Valproic Acid results in decreased expression of BNIP3 mRNA | CTD | PMID:19949822 |
| zinc oxide | increases expression | ISO | RGD:1350913 | 6480464 | Zinc Oxide results in increased expression of BNIP3 mRNA | CTD | PMID:19755143 |
| zoledronic acid | decreases expression | ISO | RGD:1350913 | 6480464 | zoledronic acid results in decreased expression of BNIP3 mRNA | CTD | PMID:19036117 |